Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.5300 (-2.87%) ($12.3500 - $13.0900) on Thu. Apr. 6, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.31% (three month average) | RSI | 29 | Latest Price | $12.5300(-2.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) ARKG(48%) IWM(48%) | Factors Impacting HALO price | HALO will decline at least -1.655% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-4%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.655% (StdDev 3.31%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
1 - 5 Day Possible Target | $4.75(-62.09%) | Resistance Level | $13.58 | 5 Day Moving Average | $12.89(-2.79%) | 10 Day Moving Average | $13.35(-6.14%) | 20 Day Moving Average | $13.58(-7.73%) | To recent high | -14.6% | To recent low | 15.1% | Market Cap | $1.712b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |